HTB homepage • Conference reports • Articles by subject • Subscribe Early access NICE fails to approve lenacapavir for HIV PrEP: will feedback lead to the right outcome in November? 9 September 2026. Related: Early access, Treatment access, HIV prevention and transmission. Merck announces alimatravir access programme ahead of AIDS 2026 24 July 2026. Related: Early access, Conference reports, HIV prevention and transmission. HTB homepage • Conference reports • Articles by subject • Subscribe